iofetamine has been researched along with Huntington Disease in 2 studies
Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.
Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment with memantine prevented the chorea movement and the progression of Huntington's disease." | 8.31 | Memantine administration prevented chorea movement in Huntington's disease: a case report. ( Hirano, M; Ikegawa, A; Kusunoki, S; Mitsui, Y; Nagai, Y; Oda, I; Saigoh, K; Samukawa, M; Yamagishi, Y; Yoshikawa, K, 2023) |
| " Treatment with memantine prevented the chorea movement and the progression of Huntington's disease." | 4.31 | Memantine administration prevented chorea movement in Huntington's disease: a case report. ( Hirano, M; Ikegawa, A; Kusunoki, S; Mitsui, Y; Nagai, Y; Oda, I; Saigoh, K; Samukawa, M; Yamagishi, Y; Yoshikawa, K, 2023) |
| "For six patients with Huntington's disease, the average caudate ratio was 29." | 1.27 | Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease. ( English, RJ; Holman, BL; Ichise, M; Johnson, KA; Morris, JH; Nagel, JS; Walshe, TM, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saigoh, K | 1 |
| Hirano, M | 1 |
| Mitsui, Y | 1 |
| Oda, I | 1 |
| Ikegawa, A | 1 |
| Samukawa, M | 1 |
| Yoshikawa, K | 1 |
| Yamagishi, Y | 1 |
| Kusunoki, S | 1 |
| Nagai, Y | 1 |
| Nagel, JS | 1 |
| Johnson, KA | 1 |
| Ichise, M | 1 |
| English, RJ | 1 |
| Walshe, TM | 1 |
| Morris, JH | 1 |
| Holman, BL | 1 |
2 other studies available for iofetamine and Huntington Disease
| Article | Year |
|---|---|
Memantine administration prevented chorea movement in Huntington's disease: a case report.
Topics: Aged; Alzheimer Disease; Chorea; Dyskinesias; Female; Humans; Huntington Disease; Iofetamine; Male; | 2023 |
Decreased iodine-123 IMP caudate nucleus uptake in patients with Huntington's disease.
Topics: Amphetamines; Caudate Nucleus; Female; Humans; Huntington Disease; Iodine Radioisotopes; Iofetamine; | 1988 |